AstraZeneca PLC (AZNCF)
130.38
-0.87
(-0.66%)
USD |
OTCM |
Jan 06, 16:00
AstraZeneca Total Assets (Quarterly): 104.92B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 317.44M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 381.82M |
| NuCana PLC | 26.14M |
| Autolus Therapeutics PLC | 827.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 64.12B |
| Shareholders Equity (Quarterly) | 40.72B |
| Debt to Equity Ratio | 0.7402 |
| Current Ratio | 0.9317 |
| Net Debt Paydown Yield | -0.10% |